(Q53585030)

15 May 2018

title

Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase. (English)

1 reference

15 May 2018

1 reference

8

Duck-Ki Yoon

1 reference

15 May 2018

author name string

Cheol-Yong Yoon

1

1 reference

15 May 2018

Young-Jun Shim

2

1 reference

15 May 2018

Eun-Ho Kim

3

1 reference

15 May 2018

Ju-Han Lee

4

1 reference

15 May 2018

Nam-Hee Won

5

1 reference

15 May 2018

Jeong-Hun Kim

6

1 reference

15 May 2018

In-Sun Park

7

1 reference

15 May 2018

Bon-Hong Min

9

1 reference

15 May 2018

language of work or name

English

0 references

publication date

1 February 2007

1 reference

15 May 2018

International Journal of Cancer

published in

1 reference

15 May 2018

volume

120

1 reference

15 May 2018

issue

4

1 reference

15 May 2018

page(s)

897-905

1 reference

15 May 2018

Pegaspargase: an alternative?

cites work

1 reference

Modulation of arginine metabolic pathways as the potential anti-tumor mechanism of recombinant arginine deiminase

21 January 2018

1 reference

Arginine deiminase enhances dexamethasone-induced cytotoxicity in human T-lymphoblastic leukemia CCRF-CEM cells.

21 January 2018

1 reference

Arginine deiminase inhibits proliferation of human leukemia cells more potently than asparaginase by inducing cell cycle arrest and apoptosis.

21 January 2018

1 reference

Apoptotic cell death of human T lymphoblastoid cells induced by arginine deiminase

21 January 2018

1 reference

In vivo anti-tumor activity of arginine deiminase purified from Mycoplasma arginini

21 January 2018

1 reference

Resistance to the anti-proliferative activity of recombinant arginine deiminase in cell culture correlates with the endogenous enzyme, argininosuccinate synthetase

21 January 2018

1 reference

Integrity and stability of the citrulline-arginine pathway in normal and tumour cell lines

21 January 2018

1 reference

Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: a method for identifying cancers sensitive to arginine deprivation

21 January 2018

1 reference

O6-(4-bromothenyl)guanine reverses temozolomide resistance in human breast tumour MCF-7 cells and xenografts

21 January 2018

1 reference

Arginine deiminase: a potential inhibitor of angiogenesis and tumour growth

21 January 2018

1 reference

Arginine deiminase and other antiangiogenic agents inhibit unfavorable neuroblastoma growth: potentiation by irradiation

21 January 2018

1 reference

Recombinant arginine deiminase as a potential anti-angiogenic agent

21 January 2018

1 reference

Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies

21 January 2018

1 reference

Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies

21 January 2018

1 reference

Recombinant arginine deiminase as a differential modulator of inducible (iNOS) and endothelial (eNOS) nitric oxide synthetase activity in cultured endothelial cells

21 January 2018

1 reference

Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.22322

1 reference

15 May 2018

1 reference

15 May 2018